Komal Joshi | Head, IR & Strategic Finance |
Richard Murray | President, CEO & Director |
Elizabeth Tréhu | Chief Medical Officer |
Kimberlee Drapkin | CFO & Treasurer |
Debjit Chattopadhyay | H.C. Wainwright & Co. |
Steven Seedhouse | Raymond James & Associates |
James Birchenough | Wells Fargo Securities |
Michael Ulz | Robert W. Baird & Co. |
James Scott | JPMorgan Chase & Co. |
Good morning, ladies and gentlemen, and welcome to Jounce Therapeutics Second Quarter 2019 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded at the company's request.
I will now turn the call over to your host, Komal Joshi with Jounce Therapeutics. Please go ahead.